Coronary vasospasm as a pathogenetic mechanism of coronary heart disease
Velican, D.
Medecine Interne 18(1): 25-43
1980
ISSN/ISBN: 0377-1202 PMID: 6990464 Document Number: 161246
An attempt is made to summarize recent available information on the coronary vasospasm as one of the pathogenetic mechanisms of coronary heart disease. The review focuses attention on the following topics: 1) spasm and the coronary artery microarchitecture; 2) spasm and the nervous system control of the coronary arteries; 3) spasm and clinical manifestations of coronary heart disease. Data are also presented on the influence of drugs on the coronary vasospasm.
Document emailed within 1 workday
Related Documents
Guénot, O.; Pellet, J.; Terraube, P.; Grosclaude, G.; Couche, L.; Legrand, M.; Arnaud-Crozat, E. 1990: Coronary vasospasm: a cause of sudden death. Case report of reversible heart arrest with spontaneous coronary spasm documented by angiography Archives des Maladies du Coeur et des Vaisseaux 83(12): 1859-1862Sommerschild, H.T. 2000: Is infection a pathogenetic factor in coronary heart disease? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(28): 3396-3403
Sommerschild, H.T. 2001: Is infection a pathogenetic factor in coronary heart disease? Ugeskrift for Laeger 163(13): 1834-1842
Kido, S.; Ishii, Y.; Hasebe, N.; Ido, A.; Kawashima, E.; Ogawa, Y.; Yamashita, H.; Kikuchi, K.; Onodera, S. 1998: Significance of coronary risk factors and coronary arteriosclerosis for coronary vasospasm Journal of Cardiology 31(3): 135-143
Opherk, D.; Mäurer, W.; Mehmel, H.C.; Müller, J.H.; Zebe, H.; Kübler, W. 1976: Coronary circulation and myocardial O2 consumption in patients with coronary heart disease under isometric load and in maximal coronary dilatation Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1188-1190
Kaikita, K.; Ogawa, H. 2016: Pathogenetic mechanism of coronary vasospastic angina Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 6): 38-42
Savchenko, A.P.; Akchurin, R.S.; Rudenko, B.A.; Shiriaev, A.A.; Cherkavskaia, O.V.; Kozlov, G.V. 2010: Long-term follow-up use of "cypher" sirolimus-eluting stents in patients with coronary heart disease after coronary artery bypass grafting with occlusive lesions of the coronary artery Vestnik Rentgenologii i Radiologii 4: 4-12
Przybojewski, J.Z. 1986: The importance of excluding coronary artery vasospasm before percutaneous transluminal coronary angioplasty. A case report South African Medical Journal 70(8): 495-499
Bernadet, P.; Marco, J.; Alibelli, M.J. 1983: Treatment of coronary artery vasospasm during coronary arteriography Archives des Maladies du Coeur et des Vaisseaux 76(Special Issue): 123-129
Carstens, V.; Haum, A.; Grond, M.; Behrenbeck, D.W. 1986: Incidence of coronary artery disease and necessity for coronary angiography in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 83-85
Leone, A.; Lopez, M.; Picerno, G. 1984: Role of smoking in determining coronary heart disease. Hypothesis on the possible mechanism of myocardial damage Minerva Cardioangiologica 32(7-8): 435-439
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Lu, G.; Xu, Z.-W.; Zhang, Y.-L.; Yang, Z.-J.; Zhang, X.-L.; Yin, K.-S. 2007: Correlation among obstructive sleep apnea syndrome, coronary atherosclerosis and coronary heart disease Chinese Medical Journal 120(18): 1632-1634
Mäurer, W.; Opherk, D.; Zebe, H.; Mehmel, H.C.; Müller, J.H.; Kübler, W. 1976: Changes of plasma-catecholamine-level in the coronary sinus of patients with coronary heart disease under stress Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1193-1196
Velican, D.; Petrescu, C.; Velican, C. 1981: The branching anatomical pattern of the coronary arteries as a risk factor for coronary heart disease Medecine Interne 19(2): 173-183
Ning, X.-h.; Xiang, X.-p.; Lu, N.; Zhang, Y.-x.; Wang, W.-j.; Liu, Y.; Zhou, Z. 2008: Relation of risk factors to coronary artery stenosis severity in coronary atherosclerotic heart disease Zhonghua Yi Xue Za Zhi 88(18): 1267-1269
Khetpal, A.; Khetpal, N.; Godil, A.; Ali Mallick, M.S.; Lashari, M.N. 2016: Anomalous right coronary artery arising from left coronary cusp with coexisting valvular heart disease JPMA. Journal of the Pakistan Medical Association 66(4): 492-494
Kelm, M.; Schäfer, S.; Preik, M.; Schoebel, F.C.; Preik-Steinhoff, H.; Strauer, B.E. 1997: Coronary vasomotion in coronary heart disease--significance of epicardial and microcirculatory vessels for myocardial perfusion Zeitschrift für Kardiologie 86(Suppl 1): 33-41
Agarwal, A.K.; Singla, S.; Singla, S.; Singla, R.; Lal, A.; Wardhan, H.; Yadav, R. 2009: Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease Journal of the Association of Physicians of India 57(1): 135-142
Iannone, L.A.; Brown, T.M.; Phillips, S.J.; Wickemeyer, W.J.; Zeff, R.H.; Wheeler, W.S.; Kongtahworn, C.; Rough, R.R.; Skinner, J.R.; Toon, R.S. 1983: Percutaneous transluminal coronary angioplasty: an added modality for the treatment of the patient with coronary heart disease Cardiologia 28(7): 625-633